Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Mã chứng khoánGRFS
Tên công tyGrifols SA
Ngày IPOMay 17, 2006
Giám đốc điều hànhMr. Jose Ignacio (Nacho) Abia
Số lượng nhân viên23833
Loại chứng khoánDepository Receipt
Kết thúc năm tài chínhMay 17
Địa chỉParque Empresarial Can Sant Joan
Thành phốSANT CUGAT DEL VALLES
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaSpain
Mã bưu điện08174
Điện thoại34935710000
Trang webhttps://www.grifols.com/
Mã chứng khoánGRFS
Ngày IPOMay 17, 2006
Giám đốc điều hànhMr. Jose Ignacio (Nacho) Abia
Tổng cộng
436.88M
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
GRFS.NB Interim Cash Dividend of gross USD 0.456586 paid on Jun 14, 2021 going ex on Jun 03, 2021
GRFS.NB Interim Cash Dividend of gross USD 0.201439 paid on Nov 09, 2020 going ex on Oct 30, 2020